Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Cassandra Spanos"'
Autor:
Ingrid Bretherton, Cassandra Spanos, Shalem Y. Leemaqz, Gehan Premaratne, Mathis Grossmann, Jeffrey D. Zajac, Ada S. Cheung
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Background: Transgender individuals receiving gender-affirming hormone therapy (GAHT) are at increased risk of adverse cardiovascular outcomes. This may be related to effects on body composition and insulin resistance. Aims: To examine relationships
Externí odkaz:
https://doaj.org/article/946874994bca416ea295151e4d66887b
Autor:
Pravik Solanki, David Colon-Cabrera, Chris Barton, Peter Locke, Ada S. Cheung, Cassandra Spanos, Julian Grace, Jaco Erasmus, Riki Lane
Publikováno v:
Transgender Health. 8:137-148
Autor:
Ada S Cheung, Adam Brownhill, Peggy Wong, Jeffrey D Zajac, Pauline Cundill, Shalem Leemaqz, Cassandra Spanos, Julian A. Grace, Peter Locke
Publikováno v:
The Journal of Sexual Medicine. 18:201-208
BACKGROUND: There are 2 common approaches to assess an individual before commencing of gender-affirming hormone therapy (GAHT); a mental health practitioner assessment and approval or an informed consent model undertaken with a primary care general p
Publikováno v:
World Journal of Diabetes
Background Transgender individuals receiving masculinising or feminising gender-affirming hormone therapy with testosterone or estradiol respectively, are at increased risk of adverse cardiovascular outcomes, including myocardial infarction and strok
Autor:
Ingrid Bretherton, Ali Ghasem‐Zadeh, Shalem Y Leemaqz, Ego Seeman, Xiaofang Wang, Thomas McFarlane, Cassandra Spanos, Mathis Grossmann, Jeffrey D Zajac, Ada S Cheung
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 37(4)
Gender-affirming hormone therapy aligns physical characteristics with an individual's gender identity, but sex hormones regulate bone remodeling and influence bone morphology. We hypothesized that trans men receiving testosterone have compromised bon
Autor:
null Ingrid Bretherton, null Ali Ghasem‐Zadeh, null Shalem Y. Leemaqz, null Ego Seeman, null Xiaofang Wang, null Thomas McFarlane, null Cassandra Spanos, null Mathis Grossmann, null Jeffrey D Zajac, null Ada S Cheung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eda81f213d48343c2792e47ab8fcd6b7
https://doi.org/10.1002/jbmr.4497/v2/response1
https://doi.org/10.1002/jbmr.4497/v2/response1
Autor:
Jeffrey D Zajac, Mathis Grossmann, Gehan Premaratne, Cassandra Spanos, Shalem Leemaqz, Ingrid Bretherton, Ada S Cheung
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Background: Transgender individuals receiving gender-affirming hormone therapy (GAHT) are at increased risk of adverse cardiovascular outcomes. This may be related to effects on body composition and insulin resistance. Aims: To examine relationships
Autor:
Thomas McFarlane, Ada S Cheung, Ingrid Bretherton, Mathis Grossmann, Jeffrey D Zajac, Cassandra Spanos
Publikováno v:
Endocrine Abstracts.